RESOLUTE ONYX Post-Approval Study (Bifurcation Cohort)
NCT03584464
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
205
Enrollment
INDUSTRY
Sponsor class
Conditions
Coronary Artery Disease
Interventions
DEVICE:
Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System
Sponsor
Medtronic Vascular